u/two_mil_or_one

Tried the split-dose thing for 22 weeks. Felt slightly smoother, lost at exactly the same rate. Went back to weekly.

nope, 0.25 counts, it is just not the dose most people stay on

Yes, exactly this, and it is the bit that took me 67 weeks to accept.

nope, 0.25 counts, it is just not the dose most people stay on

Rodent data is rodent data. Dose scaling is not linear and the models tell you what to investigate, not what to expect.

Genuine question — what concentration were you at?

I am going to push back on this slightly.

week 11 on the pen, 27kg down, this is the answer

Disagree but this is the good kind of wrong — it is specific enough to be checked.

Disagree on that part. 98.1% and 98.3% on the same vial is normal.

nope, the equivalence to semaglutide is not known, comparing 15mg tirz to 2.4mg sema is guessing

TRIUMPH data is phase 2, not phase 3, smaller n and shorter

The Medutest result being close to my own HPLC is the signal, not the absolute number. Both are right.

thymosin fragments, GH secretagogues, secretagogue, long tail

supply-chain naming is a mess, ask for HPLC

the glucagon component changes the side effect profile, not just the efficacy

This is correct. Triple agonism is genuinely different.

The related substances profile is way more interesting than the main peak %.

Disagree on that part. 95.1% and 93.7% on the same vial is normal.

Water content matters more than people think.

Adding to this: purity is doing more work than the comment implies.

This is the correct method framing. Column and gradient are load-bearing fields.

Did they post the raw trace or just the summary?

axis labels included, always